News & Media
UC San Francisco researchers have for the first time transformed human stem cells into mature insulin-producing cells, a major breakthrough in the effort to develop a cure for type 1 (T1) diabetes...
A study of human and mouse pancreatic tissue suggests a new origin story for type 1 diabetes. The findings flip current assumptions about the causes of the disease on their head and demonstrate a...
The American Association for Cancer Research (AACR) has awarded the 15th AACR-Irving Weinstein Foundation Distinguished Lectureship to Jeffrey Bluestone, PhD The AACR-Irving Weinstein Foundation...
Not to be confused with type 2 diabetes, the most common form of diabetes in which your body does not use insulin properly, type 1 diabetes is an autoimmune disease which causes the destruction of...
Originally published in Endpoint News, by John Carroll The diabetes drug Teplizumab has taken another step forward in the long, painfully slow trek out of the research and development wilderness, and...
For over a half century, UCSF researchers and clinicians have been making breakthrough discoveries that have improved diabetes treatment and care for individuals with diabetes and their families. Ten...
Premature senescent beta cells during the development of Type 1 diabetes
From UCSF School of Medicine Bridges curriculum, pioneering a new approach to medical education to prepare physicians for practice in the 21st century, Allison Xu discusses the biology behind obesity.
Stephen Gitelman MD, moderates panel discussion with Sarah Kim MD, Audrey Parent PhD, and Shylaja Srinivasan MD
This Center is a cure accelerator and a high impact partnership combining the scientific expertise of Stanford University and the University of California, San Francisco (UCSF) within the...